All of the Top Vaccine Makers Stocks Plummet After trump HHS Nomination

Source: CNBC

Shares of Moderna, Novavax, Pfizer, BioNTech and GSK closed lower on Thursday after shares of vaccine makers fell as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine critic, to lead the Department of Health and Human Services. Mainstream health policy experts have said a second Trump term could allow Kennedy to increase regulations of vaccine production and distribution, clearly the vaccine makers do not like that.

They credit Trump with opening up red tape channels that would have made the vaccine harder to manufacture during the pandemic. However after Trump left office his predecessors looked at the looser regulations [done specifically to offset pandemic logistic issues] as an opportunity to advance their goal of mass inoculation and monitoring through healthcare mandates.

A vaccine which under Trump the vaccine makers promised would be one or 2 shots for the elderly and at risk, has now under the Biden administration boldly gone up to 3 or 4 boosters a year, with no end in sight.

Trumps new administration promises to hold these people accountable as Frontline Doctors has been committed to doing since the pandemic began.